INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD sold 0.0% of their position (10.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $137.00 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2026ACC: 0001140361-26-028955
→
10% Owner
Since Jun 2026
-10.00
Net shares
Net seller
$137.00
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.00
Price / share
$13.70
Trade value
$137.00
% of position
0.0%
7/17/2026
2.86M→2.86M
Total
Net shares
−10.00
Net value
-$137.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/17/2026 | S · Sale | −10.00 | $13.70 | $137.00 | 0.0% | 2.86M | 2.86M |
| Total | −10.00 | -$137.00 | ||||||
Derivative Transactions0
No derivative transactions reported